Apollo Hospitals Enterprise Ltd logo

Apollo Hospitals Enterprise Ltd

APOLLOHOSP NSE

Key Fundamentals

LargecapHospitalsHealthcare Services
Market Cap
1.3L Cr
Volatility
Moderate
P/E Ratio
60.67
EBITDA
₹3,961 Cr
Return on Equity
20.08%
Debt to Equity
0.9
Book Value
₹659.33
EPS
₹72.05
52W High
₹9,050
52W Low
₹6,696.5

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Apollo Hospitals Enterprise Ltd insights

43 extracted metrics + investor summaries across FY15–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Strengths

2
  • Company has delivered good profit growth of 76.2% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 17.7%

Weaknesses

2
  • Stock is trading at 13.4 times its book value
  • Company might be capitalizing the interest cost

Growth Rate

Revenue Growth
15.58% ↗
Net Income Growth
33.06% ↗
Cash Flow Change
33.67% ↗
ROE
15.47% ↗
ROCE
27.43% ↗
EBITDA Margin (Avg.)
6.35% ↘

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 2d ago
AI opinion · based on fundamentals
Risk medium

Apollo Hospitals Enterprise Ltd is a large-cap healthcare services company with a market capitalization of ₹1,26,430 crore, trading at a PE of 56.9x and PB of 13.04x. The company has delivered strong profit growth of 76% CAGR over 5 years with TTM sales growth of 17% and ROE improving to 21% in the last year, though its valuation multiples remain elevated relative to book value.

Bull Case 8
  • Exceptional profit growth of 76% CAGR over 5 years demonstrates strong operating leverage and margin expansion
  • TTM sales growth of 17% and 5-year compounded sales CAGR of 19% indicate sustained revenue momentum
  • ROE has improved from 13% (10-year average) to 21% in the last year, reflecting better capital efficiency
  • 3-year compounded profit growth of 32% shows acceleration in earnings trajectory
  • 10-year stock CAGR of 20% demonstrates long-term wealth creation track record
  • Consistent dividend payout of 17.7% maintained alongside high reinvestment for growth
  • 3-year ROE of 18% and 5-year ROE of 17% show structural improvement in profitability, not a one-off spike
  • Large-cap status with ₹1,26,430 crore market cap provides institutional liquidity and index inclusion benefits
Bear Case 8
  • PE ratio of 56.9x is significantly elevated, requiring sustained high growth to justify current valuation
  • Trading at 13.04x book value leaves limited margin of safety if growth decelerates
  • Potential capitalization of interest costs may overstate reported profits and asset values
  • Dividend yield of only 0.23% offers negligible income return for shareholders at current price
  • 1-year stock CAGR of 14% has lagged the 3-year CAGR of 22%, suggesting momentum moderation
  • 5-year stock CAGR of only 13% versus 10-year CAGR of 20% indicates periods of significant underperformance relative to long-term trend
  • TTM profit growth of 34% while strong is decelerating from the 5-year CAGR of 76%, indicating base effect normalization
  • At 56.9x PE, even a minor earnings miss could trigger meaningful multiple compression given premium valuation

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 20h ago
Positives 4
  • Strong Q1 PAT up 34% Aug 12

    Apollo Hospitals reported 34% rise in net profit to ₹5,805 crore and 21% revenue growth in Q1FY27. Healthcare services segment grew 22% while HealthCo digital cash losses narrowed significantly.

  • 25% hospital margin target Aug 13

    Management targeting 25% margin in hospital business segment, signaling confidence in operational efficiency improvements.

  • Bed capacity expansion to 14,100 Aug 13

    Company aims to grow total bed capacity to 14,100 by FY31, funded majorly through internal accruals rather than external borrowing.

  • ₹20/share total FY26 dividend Aug 1

    Board recommends ₹10 final dividend per share bringing total FY26 dividend to ₹20/share, aggregating ₹2,875.70 million. AGM scheduled August 25, 2026.

Neutral 2
  • ₹44 crore block trade on BSE Jul 22

    Block trade of ~49,647 shares executed at ₹8,900 per share totaling ₹44.19 crore, likely between institutional participants.

  • Q1 FY27 results call announced Jul 21

    Conference call held August 13 at 3:00 PM IST with key management including Mrs. Suneeta Reddy and Mr. A. Krishnan to discuss Q1 FY27 results.

TL;DR: Apollo Hospitals delivered a strong Q1FY27 with 34% PAT growth and 21% revenue expansion, supported by robust healthcare services performance and narrowing digital losses. No material headwinds emerged in the review period. Management is guiding toward higher margins (25% hospital business target) and ambitious capacity expansion (14,100 beds by FY31) funded internally. The trend is clearly improving with earnings momentum and disciplined capital allocation reinforcing a bullish outlook.

Quarterly Results

  Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
4,418
4,847
4,851
4,944
5,086
5,589
5,527
5,592
5,842
6,304
6,477
6,606
7,044
Expenses
3,909
4,219
4,237
4,303
4,410
4,774
4,765
4,822
4,990
5,362
5,512
5,594
5,951
Operating Profit
509
628
614
640
675
816
762
770
852
941
965
1,011
1,092
OPM %
12%
13%
13%
13%
13%
15%
14%
14%
15%
15%
15%
15%
16%
Other Income
34
26
29
37
49
44
69
72
54
61
48
54
62
Interest
106
111
113
119
116
118
110
115
108
110
113
119
120
Depreciation
167
163
167
190
177
184
185
211
215
218
219
224
235
PBT
270
379
363
368
430
557
536
516
583
675
682
722
799
Tax %
36%
34%
30%
30%
27%
29%
29%
20%
24%
27%
24%
24%
24%
Net Profit
173
249
254
258
316
396
379
414
441
494
516
551
610
EPS in Rs
11.59
16.2
17.06
17.65
21.23
26.34
25.89
27.1
30.1
33.19
34.93
36.81
40.39
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
5,129
6,150
7,256
8,243
9,617
11,247
10,560
14,663
16,612
19,059
21,794
25,228
26,430
Expenses
4,392
5,465
6,522
7,442
8,548
9,656
9,420
12,474
14,548
16,665
18,761
21,449
22,420
Operating Profit
737
684
734
801
1,070
1,591
1,140
2,189
2,065
2,394
3,033
3,779
4,010
OPM %
14%
11%
10%
10%
11%
14%
11%
15%
12%
13%
14%
15%
15%
Other Income
47
92
60
24
26
222
103
368
75
123
222
207
226
Interest
118
180
257
295
327
533
449
379
381
449
458
450
462
Depreciation
212
264
314
359
396
620
573
601
615
687
758
876
896
PBT
455
332
222
171
373
660
221
1,578
1,144
1,380
2,039
2,661
2,877
Tax %
29%
29%
41%
65%
47%
34%
38%
30%
22%
32%
26%
25%
—
Net Profit
335
235
131
60
200
432
137
1,108
844
935
1,505
2,003
2,172
EPS in Rs
24.43
16.99
15.88
8.44
16.96
32.7
10.46
73.42
56.97
62.5
101
135
145
Div. Payout %
24%
35%
38%
59%
35%
18%
29%
16%
26%
26%
13%
15%
—
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
70
70
70
70
70
70
72
72
72
72
72
72
Reserves
3,102
3,262
3,244
3,182
3,264
3,270
4,531
5,551
6,126
6,864
8,140
9,408
Borrowings
1,992
2,834
3,125
3,427
3,673
3,596
4,160
4,068
4,332
5,333
7,864
8,493
Other Liabilities
1,296
1,195
1,665
1,917
2,159
4,354
2,629
3,570
3,886
4,474
4,568
4,210
Total Liabilities
6,459
7,360
8,103
8,596
9,166
11,289
11,392
13,261
14,416
16,742
20,644
22,183
Fixed Assets
3,244
3,997
4,591
4,773
4,982
7,432
6,778
8,296
8,520
9,664
10,988
12,272
CWIP
533
562
347
712
822
236
234
46
610
873
921
1,032
Investments
311
352
406
352
462
434
1,343
816
574
986
2,487
2,179
Other Assets
2,372
2,448
2,759
2,759
2,901
3,187
3,037
4,104
4,712
5,219
6,248
6,700
Total Assets
6,459
7,360
8,103
8,596
9,166
11,289
11,392
13,261
14,416
16,742
20,644
22,183
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
470
597
623
537
905
1,293
1,265
1,696
1,377
1,920
2,136
2,856
Investing
-759
-888
-1,152
-405
-711
-289
-880
-747
-857
-1,537
-3,383
-2,145
Financing
392
330
477
-108
-215
-910
-340
-792
-633
-311
1,319
-478
Net Cash Flow
103
39
-52
24
-20
94
44
158
-113
72
73
233
Free Cash Flow
-396
-393
-46
-84
233
782
984
1,044
252
785
439
925
CFO/OP
77
108
103
83
103
100
108
87
85
100
86
92
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
43
36
38
37
39
33
46
44
49
48
51
50
Inventory Days
50
49
47
51
46
49
16
21
17
17
16
15
Days Payable
59
66
51
55
56
60
74
79
82
88
72
63
Cash Conversion Cycle
34
19
34
33
29
22
-12
-14
-16
-23
-6
3
Working Capital Days
24
16
27
8
-3
-8
-4
5
-1
-19
-6
-25
ROCE %
12%
9%
8%
7%
10%
14%
8%
17%
14%
15%
17%
17%

Shareholding Pattern

As of Jun 2026
FIIs 41.50%
Promoters 28.02%
DIIs 23.72%
Public 4.48%
Others 2.05%
Government 0.23%
Total 100.00%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
29.82%
29.82%
29.82%
29.33%
29.33%
29.33%
29.33%
29.33%
29.33%
29.33%
29.33%
29.33%
29.33%
29.33%
29.33%
29.33%
29.34%
29.34%
28.02%
28.02%
28.02%
28.02%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
45.63%
43.92%
45.37%
45.27%
42.74%
43.49%
44.20%
43.54%
42.62%
41.50%
DIIs
9.16%
10.84%
12.24%
12.13%
12.45%
14.89%
14.59%
16.56%
17.76%
16.31%
18.60%
17.97%
19.55%
21.14%
19.95%
19.98%
22.29%
21.34%
21.12%
21.51%
22.76%
23.72%
Government
0.23%
0.23%
0.23%
0.23%
0.23%
0.23%
0.23%
0.23%
0.23%
0.23%
0.23%
0.23%
0.23%
0.23%
0.23%
0.23%
0.23%
0.23%
0.23%
0.23%
0.23%
0.23%
Public
4.07%
3.99%
4.24%
4.03%
4.27%
4.48%
4.23%
4.13%
4.04%
3.90%
4.04%
3.70%
3.74%
3.81%
3.62%
3.65%
3.81%
3.98%
4.44%
4.70%
4.39%
4.48%
Others
56.73%
55.13%
53.47%
54.29%
53.73%
51.07%
51.63%
49.75%
48.64%
50.23%
47.80%
48.76%
1.52%
1.57%
1.50%
1.54%
1.60%
1.62%
1.99%
2.01%
1.98%
2.05%
No. of Shareholders
67,091
75,153
98,452
99,135
1,26,226
1,46,320
1,35,923
1,31,636
1,31,937
1,20,030
1,31,565
1,19,578
1,30,664
1,27,754
1,19,245
1,27,802
1,34,058
1,41,007
1,60,556
1,78,648
1,74,610
1,74,281

Documents

Frequently Asked Questions about Apollo Hospitals Enterprise Ltd

What does Apollo Hospitals Enterprise Ltd do?
Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country. Apollo Hospitals has emerged as Asia’s foremo...
Where is Apollo Hospitals Enterprise Ltd (APOLLOHOSP) listed?
Apollo Hospitals Enterprise Ltd is listed on the Indian stock exchanges. It is listed on NSE: APOLLOHOSP and BSE: 508869. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Apollo Hospitals Enterprise Ltd belong to?
Apollo Hospitals Enterprise Ltd operates in the Healthcare Services sector within the Hospitals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Apollo Hospitals Enterprise Ltd?
Apollo Hospitals Enterprise Ltd has a market capitalisation of approximately ₹127738.29 Cr. Based on this, it is classified as a Large Cap stock.
What is the PE ratio of Apollo Hospitals Enterprise Ltd?
The Price-to-Earnings (PE) ratio of Apollo Hospitals Enterprise Ltd is 60.67. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Apollo Hospitals Enterprise Ltd?
Over the past 52 weeks, Apollo Hospitals Enterprise Ltd has traded between a low of ₹6,696.5 and a high of ₹9,050. This range helps investors understand the stock's price volatility and recent trading levels.
Does Apollo Hospitals Enterprise Ltd pay dividends?
Yes, Apollo Hospitals Enterprise Ltd has a dividend yield of 0.23%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Apollo Hospitals Enterprise Ltd?
Apollo Hospitals Enterprise Ltd has a Return on Equity (ROE) of 20.08%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Apollo Hospitals Enterprise Ltd on Tapetide?
On Tapetide, you can view Apollo Hospitals Enterprise Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country. Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics and several Retail Health models. [1]

Website apollohospitals.com
CEO Dr. Prathap Chandra Reddy FCCP, FICA, FRCS, M.D., MBBS
Employees 42,497
Listed 1996-01-10
Face Value ₹ 5
Issued Size 14,37,84,657

Explore More

More in Healthcare Services → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List